BioSpace News Archive

May is National High Blood Pressure Education Month and global heart health leader OMRON Healthcare, Inc., is issuing a national alert to remind Americans that knowing your blood pressure status is essential to managing risk for heart attack, stroke, and other health conditions, including increased risks associated with COVID-19 infection

Hand hygiene management system protects against the threat and spread of illness with a hand scanner that tracks handwashing frequency and effectiveness

For the tenth year in a row, Kaiser Permanente has earned the Pharmacy Quality Alliance Excellence in Quality Award for high achievement in medication safety and appropriate use.

- Abbott’s antibody test to be deployed as part of the UK Secretary of State for Health’s initiative for highly-reliable, large-scale antibody testing - European-made blood test will run on Abbott’s ARCHITECT® i1000SR and i2000SR, as well as its Alinity™ i laboratory instruments - 800,000 Abbott tests have already been delivered to NHS laboratories across the UK - Test demonstrated reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 d

Bioinsider LLC (Bioinsider), a company dedicated to creating a quality, unbiased virtual meeting platform for communication among the scientific, policymaker and business communities, has opened registration and a call for speaker proposals for its four-part virtual meeting series, Together as One COVID-19 Series.

Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the “notification list” of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency . Antibody tests on this new removal list include those voluntarily withdrawn from the notif

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it will host a conference call and audio webcast on Thursday, May 28, 2020 at 1:30 pm PT / 4:30 pm ET to report its first quarter 2020 financial results and provide an update on recent business progress.

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, announced today that it is changing the format of its 2020 annual meeting of shareholders (the “2020 Annual Meeting”)

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced it will host a conference call and audio webcast on Friday, May 29 at 4:30 p.m. ET.

Amarin Corporation plc (NASDAQ:AMRN), today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA®) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19.